The role of biomarkers in cardiotoxicity prevention and monitoring
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
The role of biomarkers in cardiotoxicity prevention and monitoring
03 Feb 2020
Listen to Professor Zamorano interviewing Dr. Cardinale.
The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.
Our mission: To reduce the burden of cardiovascular disease.
Our mission: To reduce the burden of cardiovascular disease.